The USTR said India’s limits on the approval of pharmaceutical patents, a convoluted process for patent challenges and the fact that the government was considering opening a series of patented drugs to generic manufacturers created “serious challenges” for some innovators.
But advocates for health rights say India is not breaking any rules and see the country as a global leader in providing life saving medication to the poor. (Reuters)
bet9ja payment methods - how can I fund my account?
banker of the day - FREE banker tips from experts
banker of the day - FREE banker tips from experts
Page 2 of 2